Medical Innovation Acceleration Act of 2025

Introduced Jan 3, 2025Latest action Jan 3, 2025Health

Plain-English summary

Medical Innovation Acceleration Act of 2025 This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.

Deterministically condensed from the official CRS summary; verify details in the official record.

Issue relevance

Why this appears in Paper Trail

Healthcare

Matched from official metadata: policy_area: Health

People and recorded decisions

Sponsors, Cosponsors & House Votes

Andy Biggs

Sponsor · Republican · AZ

No linked House roll-call vote is available yet. Senate votes are not currently synchronized.

Official Subjects

Health

Sources & text

Official Congress.gov record ↗Introduced in House ↗Introduced in House ↗Introduced in House ↗

Congress.gov data last updated Sep 25, 2026. Automated summaries preserve a source version and generation timestamp; human edits are explicitly recorded.